[HTML][HTML] Glycemia reduction in type 2 diabetes—microvascular and cardiovascular outcomes
GRADE Study Research Group - New England Journal of …, 2022 - Mass Medical Soc
… other medications have been shown to have neutral effects 7 or potentially harmful side effects.
… or dyslipidemia at baseline, which is typical for a population with type 2 diabetes mellitus. …
… or dyslipidemia at baseline, which is typical for a population with type 2 diabetes mellitus. …
High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus
IMJR Artha, A Bhargah, NK Dharmawan… - Vascular Health and …, 2019 - Taylor & Francis
… Cardiovascular-related morbidity and mortality are common complications in diabetes and
could be associated with dyslipidemia. So, control of lipid profiles and glycemic index is a …
could be associated with dyslipidemia. So, control of lipid profiles and glycemic index is a …
Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China
H Yang, D Young, J Gao, Y Yuan, M Shen… - Lipids in health and …, 2019 - Springer
… We showed a positive association between dyslipidemia and DKD, but negative with DR,
which may be explained by different mechanisms of action of blood lipids on these …
which may be explained by different mechanisms of action of blood lipids on these …
Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors
… patients, in such a way that CVR is reduced without any significant side effects. In recent years,
there have … Canagliflozin and cardiovascular and renal events in type 2 diabetes. N. Engl. …
there have … Canagliflozin and cardiovascular and renal events in type 2 diabetes. N. Engl. …
[HTML][HTML] … and quercetin combination ameliorates hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced type 2 diabetes mellitus in wistar rats
V Jaishree, S Narsimha - Biomedicine & Pharmacotherapy, 2020 - Elsevier
… have shown measurable adverse effects and worsened the diabetic condition rather than …
of natural products as potent drugs with negligible adverse effects in the treatment of DM. As …
of natural products as potent drugs with negligible adverse effects in the treatment of DM. As …
Association of serum cholesterol levels with peripheral nerve damage in patients with type 2 diabetes
JME Jende, JB Groener, C Rother, Z Kender… - JAMA network …, 2019 - jamanetwork.com
… Importance Lowering serum cholesterol levels is a well-established treatment for
dyslipidemia in patients with type 2 diabetes (T2D). However, nerve lesions in patients with T2D …
dyslipidemia in patients with type 2 diabetes (T2D). However, nerve lesions in patients with T2D …
Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies
X Ye, W Kong, MI Zafar, LL Chen - Cardiovascular diabetology, 2019 - Springer
… general population; however, their relationship in patients with type 2 diabetes mellitus (T2DM)
is uncertain. We aimed to assess the association of TG with CVD in T2DM individuals. …
is uncertain. We aimed to assess the association of TG with CVD in T2DM individuals. …
[HTML][HTML] Long-term complications in youth-onset type 2 diabetes
TODAY Study Group - New England Journal of Medicine, 2021 - Mass Medical Soc
… The cumulative incidence of hypertension was 67.5%, the incidence of dyslipidemia was
51.6%, the incidence of diabetic kidney disease was 54.8%, and the incidence of nerve …
51.6%, the incidence of diabetic kidney disease was 54.8%, and the incidence of nerve …
The relationship between type 2 diabetes, NAFLD, and cardiovascular risk
C Caussy, A Aubin, R Loomba - Current diabetes reports, 2021 - Springer
… extra-hepatic complications such as cardio-metabolic diseases including type 2 diabetes
mellitus (T2DM), dyslipidemia, metabolic syndrome, and cardiovascular diseases (CVD) […
mellitus (T2DM), dyslipidemia, metabolic syndrome, and cardiovascular diseases (CVD) […
Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus
J Blahova, M Martiniakova, M Babikova, V Kovacova… - Pharmaceuticals, 2021 - mdpi.com
… Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by
chronic … Mechanisms of their action and possible negative side effects are also provided. …
chronic … Mechanisms of their action and possible negative side effects are also provided. …